Pediatric immunohematopoietic stem cell transplantation at a tertiary care center in Cape Town

Abstract

Our analysis indicates that the standardized preparative regimen, coupled with a now well-established immunosuppressive regimen, is as effective in patients under 18 years of age as in adults. Our analysis also indicates that in a resource-scarce or developing country, it is mandatory to limit high-risk and relatively expensive procedures to active teams that enjoy international accreditation, whether these be in the state or private sector.

Once fat was fat and that was that : our changing perspectives on adipose tissue

“…Also, the long-term safety of the use of these cells in humans must be explored, initially by the development of the appropriate animal models. Stem-cell therapy is already available for the treatment of haematological malignancies in specialised medical centres within Africa 139 and therefore it is feasible that the therapeutic use of ADSCs may also become a reality for this continent.…”